Grc Electrical
Solar Engineer, Installer, Electrician, Designer
Green Safaris
Operations, Maintenance and Environmental Support Manager
Protec Training Facility Nemo Classic Diving Jan 2016 - Jan 2017
Instructor and Technician
Superflytt Jan 2016 - Oct 2016
Logistics Coordinator
Kaya Mawa Oct 2014 - Oct 2015
Lodge and Operations Manager
New York Life Insurance Company May 2004 - Jul 2012
2Nd Vice President
New York Life Insurance Company May 2004 - Jul 2012
Vice President - Stable Value at New York Life Investments
Chatham Partners Aug 2001 - Apr 2004
Team Leader
Education:
Colby College 1996 - 2000
Bachelors, Bachelor of Arts, Economics, Mathematics
Dana-Farber Cancer Institute since Sep 2010
Research Scientist, Experimental Medicine Department
Alnylam Pharmaceuticals Feb 2008 - Nov 2009
Associate Director, Immunoassay Development
Point Therapeutics, Inc. Apr 2002 - Dec 2006
Senior Scientist
Zycos, Inc. Dec 1997 - Mar 2002
Senior Scientist
St. Jude Children's Research Hospital Jan 1992 - Aug 1997
Post Doc
Education:
University of Maryland Baltimore County 1982 - 1989
Ph.D., Biological Sciences (Immunology)
Gettysburg College 1978 - 1982
B.A., Biology
McDonogh School
Skills:
Immunoassays Molecular Biology Cell Biology Tissue Culture Pharmaceutical Industry Vaccines Immunology Virology Clinical Research Life Sciences Biotechnology Small Animal Models Multi Color Flow Cytometry Virus Culture T Cells Animal Work Protein Chemistry Cell Cancer Project Management Pbmc Isolation Signal Transduction Glp Assay Development Cell Culture Genetics Elisa Drug Discovery Fda Infectious Diseases Inflammation High Throughput Screening Genomics Cancer Research Rnai Biochemistry Flow Cytometry
Interests:
Investing Electronics Home Improvement Reading Music Sports Movies
Nazneen Aziz - Lexington MA, US Mary Lynne Hedley - Lexington MA, US Robert G. Urban - Lexington MA, US Andrew J. Tomlinson - Wayland MA, US Geoffrey Cole - Malden MA, US
The present invention provides nucleic acids containing transcriptional units that encode CYP1B1 polypeptides or portions thereof, wherein the transcriptional units lack sequences found in the untranslated region (UTR) of naturally occurring forms of the CYP1B1 transcript. The nucleic acids of the invention lack translational repressor elements and thus provide for a system of enhanced translation of the CYP1B1 polypeptide or portions thereof. Also disclosed are methods of administering nucleic acids to a mammal and use in the treatment of proliferative disorders or cancer.
Nazneen Aziz - Lexington MA, US Mary Lynne Hedley - Lexington MA, US Robert G. Urban - Lexington MA, US Andrew J. Tomlinson - Wayland MA, US Geoffrey Cole - Malden MA, US
Assignee:
Eisai Inc. - Woodcliff Lake NJ
International Classification:
A61K 48/00
US Classification:
514 44R
Abstract:
The present invention provides nucleic acids containing transcriptional units that encode CYP1B1 polypeptides or portions thereof, wherein the transcriptional units lack sequences found in the untranslated region (UTR) of naturally occurring forms of the CYP1B1 transcript. The nucleic acids of the invention lack translational repressor elements and thus provide for a system of enhanced translation of the CYP1B1 polypeptide or portions thereof. Also disclosed are methods of administering nucleic acids to a mammal and use in the treatment of proliferative disorders or cancer.
Nazneen Aziz - Lexington MA, US Mary Lynne Hedley - Lexington MA, US Robert G. Urban - Lexington MA, US Andrew J. Tomlinson - Wayland MA, US Geoffrey Cole - Malden MA, US
Assignee:
Eisai, Inc. - Woodcliff Lake NJ
International Classification:
A61K 39/00 A61P 35/00 C12N 15/53
US Classification:
4241851, 536 232
Abstract:
The present invention provides nucleic acids containing transcriptional units that encode CYP1B1 polypeptides or portions thereof, wherein the transcriptional units lack sequences found in the untranslated region (UTR) of naturally occurring forms of the CYP1B1 transcript. The nucleic acids of the invention lack translational repressor elements and thus provide for a system of enhanced translation of the CYP1B1 polypeptide or portions thereof. Also disclosed are methods of administering nucleic acids to a mammal and use in the treatment of proliferative disorders or cancer.
Name / Title
Company / Classification
Phones & Addresses
Geoffrey Cole CEO
Emerson Hospital General Medical and Surgical Hospitals
133 Old Road To 9 Acre Cor, West Concord, MA 01742 Website: emersonhospital.org
Geoffrey F. Cole President
Emerson Pathology Associates, Inc Health/Allied Services · Medical Laboratory
133 Old Rd To 9 Acre Cor, West Concord, MA 01742
Geoffrey F. Cole Principal
Emerson Occupational Health Services In Services-Misc
Some people are allergic to the vaccination, but that's very rare, said Dr. Geoffrey Cole, the chief medical officer for Health Plan Select and Athens Regional Physician Services. The two entities are a part of the Athens Regional Health Services.